(Q41243161)

English

AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection (English)

1 reference

Europe PubMed Central

28 September 2017

0 references

0 references

hepatobiliary disease

1 reference

based on heuristic

inferred from title

author name string

Wilcox CM

1

1 reference

Europe PubMed Central

28 September 2017

Rabeneck L

2

1 reference

Europe PubMed Central

28 September 2017

Friedman S

3

1 reference

Europe PubMed Central

28 September 2017

language of work or name

0 references

publication date

1 December 1996

1 reference

Europe PubMed Central

28 September 2017

Gastroenterology

1 reference

Europe PubMed Central

28 September 2017

111

1 reference

Europe PubMed Central

28 September 2017

6

1 reference

Europe PubMed Central

28 September 2017

1724-1752

1 reference

Europe PubMed Central

28 September 2017

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The changing spectrum of AIDS index diseases in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Incidence Of Clinical Aids Conditions In A Cohort Of Homosexual Men With CD4+ Cell Counts <100/mm3

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Body composition studies in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Incidence of malnutrition in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Gastrointestinal symptoms in ambulatory HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Gastrointestinal symptoms in patients infected with human immunodeficiency virus: relevance of infective agents isolated from gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The slim disease in African patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

AIDS in Uganda--clinical and social features

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Contribution of tuberculosis to slim disease in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical risk factors for malnutrition in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Current concepts in immune derangement due to undernutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Vitamins and minerals in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Micronutrients and HIV-1 disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex, and serologically positive human immunodeficiency virus patients: correlations with nutritional status

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Preservation of short-term energy balance in clinically stable patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Energy expenditure and wasting in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Enteropathy associated with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Protein-losing enteropathy and hypoalbuminemia in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Ileal and jejunal absorptive function in patients with AIDS and enterococcidial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Effects of enteric parasitoses and HIV infection upon small intestinal structure and function in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Quantitative histological study of enteropathy associated with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Absence of an Association Between Enteric Parasites in the Manifestations and Pathogenesis of HIV Enteropathy in Gay Men

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Resting energy expenditure is increased in stable, malnourished HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Increased resting energy expenditure in human immunodeficiency virus-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Protein and energy substrate metabolism in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Evidence of endocrine involvement early in the course of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Endocrine function in 98 HIV-infected patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Tumour necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Enteral alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Risks and benefits of home parenteral nutrition in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Long-term central venous catheters in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Total parenteral nutrition and cancer clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Megestrol acetate therapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Megestrol acetate in patients with AIDS-related cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Megestrol acetate in patients with AIDS and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Effect of dronabinol on nutritional status in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Infectious diarrhea in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Diagnostic workup strategies for patients with HIV-related chronic diarrhea. What is the end result?

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Intestinal infections in patients with acquired immunodeficiency syndrome. A prospective study in 132 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

A prospective evaluation of Mycobacterium avium complex colonization of the respiratory and gastrointestinal tracts of persons with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Disease due to the Mycobacterium avium complex in patients infected with human immunodeficiency virus: diagnosis and susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Gastro-intestinal involvement in Mycobacterium avium-intracellulare infection of patients with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Mycobacterium avium-intracellulare: A Cause of Disseminated Life-Threatening Infection in Homosexuals and Drug Abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Timing of symptoms and oocyst excretion in human cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cryptosporidium infection and CD4 counts

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Intensity of infection in AIDS-associated cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Treatment of intestinal cryptosporidiosis with spiramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cryptosporidial diarrhoea in AIDS and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Resolution of intestinal cryptosporidiosis after treatment of AIDS with AZT.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cytomegalovirus infections in homosexual men. An epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Gastrointestinal cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cytomegalovirus colitis. Report of the clinical, endoscopic, and pathologic findings in two patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Atypical cytomegalovirus inclusions in gastrointestinal biopsy specimens from patients with the acquired immunodeficiency syndrome: diagnostic role of in situ nucleic acid hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Histological diagnosis of intestinal microsporidiosis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Observations on the pathological spectrum and clinical course of microsporidiosis in men infected with the human immunodeficiency virus: follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Septata intestinalis N. G., N. Sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Human microsporidial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Use of light microscopy to diagnose small-intestinal microsporidiosis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Intracellular development of Enterocytozoon, a unique microsporidian found in the intestine of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

AIDS enteropathy: what's in a name?

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Efficient management of diarrhea in the acquired immunodeficiency syndrome (AIDS). A medical decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The value of barium enema and colonoscopy in patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Pathologic features of the liver in acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Granulomatous involvement of the liver in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Surgical pathology of the liver in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Tuberculosis and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Visceral bacillary epithelioid angiomatosis: possible manifestations of disseminated cat scratch disease in the immunocompromised host: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cutaneous Vascular Lesions and Disseminated Cat-Scratch Disease in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Histoplasmosis in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Coccidioidomycosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Blastomycosis in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Pneumocystis carinii hepatitis in the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Splenic infection simulating lymphoma: an unusual presentation of disseminated Pneumocystis carinii infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Microsporidan hepatitis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Reappearance of Hepatitis B Virus in Immune Patients Infected with the Human Immunodeficiency Virus Type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Hepatitis C virus infection in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Prevalence of Antibody to Hepatitis C Virus in Patients Infected with the Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

HCV vertical transmission in infants born to HIV-HCV seropositive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Neoplasms of the Gastrointestinal Tract and Hepatobiliary System in Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Biopsy pathology of acquired immune deficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Hepatomegaly with severe steatosis in HIV-seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Disruption of mitochondrial energetics and DNA synthesis by the anti-AIDS drug dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Iron overload in multiply transfused patients who are HIV seropositive

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Hepatic amyloidosis in intravenous drug abusers and AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Identification and quantitation of HIV-1 in the liver of patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Interaction of cultured human Kupffer cells with HIV-infected CEM cells: an electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Interaction of human immunodeficiency virus with human macrovascular endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

The liver in the acquired immunodeficiency syndrome: a clinical and histologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Papillary stenosis and sclerosing cholangitis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Biliary tract obstruction in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

AIDS-related cholangitis: diagnostic features and course in 15 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Human Immunodeficiency Virus-Associated Biliary Tract Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Diagnosis, and prognosis of AIDS-related cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cholestasis and disseminated cytomegalovirus disease in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cryptosporidiosis of the biliary tract in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Cholecystectomy for cholecystitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Isospora belli infection associated with acalculous cholecystitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Abdominal abnormalities in AIDS: detection at US in a large population

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

AIDS-related non-Hodgkin's lymphoma: abdominal CT findings in 112 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Ultrasound findings in hepatic mycobacterial infections in patients with acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Liver-spleen scintigraphy in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Laparoscopic and histologic findings in patients with the human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Long-term follow-up of endoscopic retrograde cholangiopancreatography sphincterotomy for patients with acquired immune deficiency syndrome papillary stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Laparoscopic surgery in patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

HIV wasting syndrome in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta 2-microglobulin and other early predictors of human immunodeficiency virus type 1-related wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight loss in HIV-1 infection is associated with immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum carotene deficiency in HIV-infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacteria in stool specimens: the nonvalue of smears for predicting culture results

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptides in the gastrointestinal tract in human immunodeficiency virus infection. The GI/HIV Study Group of the University of Calgary

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus reactivation or reinfection associated with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing incidence of Kaposi's sarcoma among patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2896%2970040-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0016-5085(96)70040-9

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41243161&oldid=2095308288"